CCDC110 antibody

Principal name

CCDC110 antibody

Alternative names for CCDC110 antibody

KMHN1, KM-HN-1, CT52, Coiled-coil domain-containing protein 110, Cancer/testis antigen KM-HN-1, Cancer/testis antigen 52

SwissProt ID

Q3V125 (Mouse), Q8TBZ0 (Human)

Gene ID

256309 (CCDC110)

Available reactivities

Hu (Human), Ms (Mouse)

Available hosts

Rabbit

Available applications

Western blot / Immunoblot (WB), Paraffin Sections (P)

Background of CCDC110 antibody

Transient overexpression lysate of coiled-coil domain containing 110 (CCDC110), transcript variant 1

General readings

Monji, M., et al. Clin. Cancer Res. 10 (18 PT 1), 6047-6057 (2004)

9 Item(s)

per page

Primary Antibodies

Catalog No. Host Iso. Clone Pres. React. Applications  

CCDC110 antibody

WB Suggested Anti-CCDC110 Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1:1562500; Positive Control: Hela cell lysate Rabbit IgG Purified Hu WB
50 µg / €325.00
  OriGene Technologies, Inc.

CCDC110 (C-term) antibody

CCDC110 Antibody (C-term) (Cat. #AP50758PU-N)immunohistochemistry analysis in formalin fixed and paraffin embedded human testis carcinoma followed by peroxidase conjugation of the secondary antibody and DAB staining.This data demonstrates the use of CCDC110 Antibody (C-term) for immunohistochemistry. Clinical relevance has not been evaluated. Rabbit Ig Aff - Purified Hu, Ms P, WB
0.4 ml / €370.00
  Acris Antibodies GmbH

CCDC110 (Center) antibody

Human HeLa; WB Suggested Anti-CCDC110 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:1562500. Positive Control: Hela cell lysate; CCDC110 antibody - middle region (ARP55544_P050) in Human HeLa cells using Western Blot Rabbit Aff - Purified Hu WB
50 µg / €350.00
  AVIVA Systems Biology

Proteins & Growth Factors

Catalog No. Species Pres. Purity Source  

CCDC110

CCDC110 Human Purified
2 µg / €300.00
  Abnova Taiwan Corp.

Lysates

Catalog No.    

CCDC110 overexpression lysate

CCDC110 overexpression lysate  
0.1 mg / €280.00
  OriGene Technologies, Inc.

Human Lenti ORF Particles

Catalog No.    

Lenti ORF particles, CCDC110 (mGFP-tagged) - Human coiled-coil domain containing 110 (CCDC110), transcript variant 1, 200 uL, >10^7 TU/mL

Lenti ORF particles, CCDC110 (mGFP-tagged) - Human coiled-coil domain containing 110 (CCDC110), transcript variant 1, 200 uL, >10^7 TU/mL  
200 µl / €1,050.00
  OriGene Technologies, Inc.

Lenti ORF particles, CCDC110 (mGFP-tagged)-Human coiled-coil domain containing 110 (CCDC110), transcript variant 2, 200 uL, >10^7 TU/mL

Lenti ORF particles, CCDC110 (mGFP-tagged)-Human coiled-coil domain containing 110 (CCDC110), transcript variant 2, 200 uL, >10^7 TU/mL  
200 µl / €1,050.00
  OriGene Technologies, Inc.

Lenti ORF particles, CCDC110 (Myc-DDK tagged) - Human coiled-coil domain containing 110 (CCDC110), transcript variant 1 , 200 uL, >10^7 TU/mL

Lenti ORF particles, CCDC110 (Myc-DDK tagged) - Human coiled-coil domain containing 110 (CCDC110), transcript variant 1 , 200 uL, >10^7 TU/mL  
200 µl / €940.00
  OriGene Technologies, Inc.

Lenti ORF particles, CCDC110 (Myc-DDK-tagged)-Human coiled-coil domain containing 110 (CCDC110), transcript variant 2, 200 uL, >10^7 TU/mL

Lenti ORF particles, CCDC110 (Myc-DDK-tagged)-Human coiled-coil domain containing 110 (CCDC110), transcript variant 2, 200 uL, >10^7 TU/mL  
200 µl / €940.00
  OriGene Technologies, Inc.

9 Item(s)

per page
  • LinkedIn